Published in Eur J Med Chem on May 27, 2011
Apoptotic death of cancer stem cells for cancer therapy. Int J Mol Sci (2014) 0.86
[Factors influencing mobilisation of endothelial progenitor cells and angiogenic cytokines after an extensive acute myocardial infarction]. Med Clin (Barc) (2011) 1.39
Identification of novel cyclooxygenase-2 selective inhibitors using pharmacophore models. J Med Chem (2002) 1.24
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy. J Transl Med (2012) 0.97
Diversity-oriented synthesis. Chem Rec (2008) 0.92
Studies on RNA integrity and gene expression in human myocardial tissue, pericardial fluid and blood, and its postmortem stability. Forensic Sci Int (2013) 0.91
Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem (2006) 0.91
Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. J Neurosci Res (2009) 0.89
New gene therapy strategies for cancer treatment: a review of recent patents. Recent Pat Anticancer Drug Discov (2012) 0.87
5-Fluorouracil derivatives: a patent review. Expert Opin Ther Pat (2012) 0.87
Serum cytokine profile in patients with pancreatic cancer. Pancreas (2014) 0.86
Role of alpha-actin in muscle damage of injured athletes in comparison with traditional markers. Br J Sports Med (2007) 0.86
Cancer stem cells and their implication in breast cancer. Eur J Clin Invest (2014) 0.86
Human cardiac tissue induces transdifferentiation of adult stem cells towards cardiomyocytes. Cytotherapy (2010) 0.86
The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells. PLoS One (2011) 0.84
Nanomedicine: application areas and development prospects. Int J Mol Sci (2011) 0.84
Homochiral drugs: a demanding tendency of the pharmaceutical industry. Curr Med Chem (2009) 0.84
Assessment of reference ranges for blood Cu, Mn, Se and Zn in a selected Italian population. J Trace Elem Med Biol (2011) 0.84
Pyrazoles and pyrazolines as neural and inducible nitric oxide synthase (nNOS and iNOS) potential inhibitors (III). Eur J Med Chem (2008) 0.84
Growth inhibition, G(1)-arrest, and apoptosis in MCF-7 human breast cancer cells by novel highly lipophilic 5-fluorouracil derivatives. Invest New Drugs (2004) 0.83
5-fluorouracil derivatives induce differentiation mediated by tubulin and HLA class I modulation. Med Chem (2007) 0.83
Cadmium modifies the cell cycle and apoptotic profiles of human breast cancer cells treated with 5-fluorouracil. Int J Mol Sci (2013) 0.83
Cross-species chromosome painting tracks the independent origin of multiple sex chromosomes in two cofamiliar Erythrinidae fishes. BMC Evol Biol (2011) 0.83
Functionalized nanostructures with application in regenerative medicine. Int J Mol Sci (2012) 0.83
Novel drug delivery system based on docetaxel-loaded nanocapsules as a therapeutic strategy against breast cancer cells. Int J Mol Sci (2012) 0.83
Exogenous nucleosides modulate proliferation of rat intestinal epithelial IEC-6 cells. J Nutr (2007) 0.82
Influence of the linker in bispyridium compounds on the inhibition of human choline kinase. J Med Chem (2004) 0.82
Inhibition of immune complex-mediated neutrophil oxidative metabolism: a pharmacophore model for 3-phenylcoumarin derivatives using GRIND-based 3D-QSAR and 2D-QSAR procedures. Eur J Med Chem (2007) 0.82
Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors. Eur J Med Chem (2012) 0.82
Capsular origin of the long head of the biceps brachii tendon: a clinical case. Rom J Morphol Embryol (2010) 0.82
A point mutation, R59G, within the HMG-SRY box in a female 45,X/46,X, psu dic(Y)(pter-->q11::q11-->pter). Hum Genet (2002) 0.81
4,5-dihydro-1H-pyrazole derivatives with inhibitory nNOS activity in rat brain: synthesis and structure-activity relationships. J Med Chem (2004) 0.81
New (RS)-benzoxazepin-purines with antitumour activity: The chiral switch from (RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine. Eur J Med Chem (2010) 0.81
Reverse transcriptase-polymerase chain reaction detection of circulating tumor cells in patients with melanoma: correlation with clinical stage, tumor thickness and histological type. Pathol Int (2002) 0.81
A synthetic uracil derivative with antitumor activity through decreasing cyclin D1 and Cdk1, and increasing p21 and p27 in MCF-7 cells. Breast Cancer Res Treat (2006) 0.80
The M3/M4 cytoplasmic loop of the alpha1 subunit restricts GABAARs lateral mobility: a study using fluorescence recovery after photobleaching. Cell Motil Cytoskeleton (2006) 0.80
Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration. Stem Cells Dev (2011) 0.80
Differentiation of intestinal epithelial cells mediated by cell confluence and/or exogenous nucleoside supplementation. Cells Tissues Organs (2010) 0.80
Antitumor properties of natural compounds and related molecules. Recent Pat Anticancer Drug Discov (2013) 0.80
Symmetrical bis-quinolinium compounds: new human choline kinase inhibitors with antiproliferative activity against the HT-29 cell line. J Med Chem (2005) 0.80
5-Fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer. Int J Nanomedicine (2012) 0.80
Anticancer activity of (1,2,3,5-tetrahydro-4,1-benzoxazepine-3-yl)-pyrimidines and -purines against the MCF-7 cell line: Preliminary cDNA microarray studies. Bioorg Med Chem Lett (2008) 0.79
Novel 4-amino bis-pyridinium and bis-quinolinium derivatives as choline kinase inhibitors with antiproliferative activity against the human breast cancer SKBR-3 cell line. ChemMedChem (2012) 0.79
Reduction of different electron-poor N-heteroarylhydrazines in strong basic conditions. Chemistry (2007) 0.79
Molecular and physical characterization of the complex pericentromeric heterochromatin of the vole species Microtus thomasi. Cytogenet Genome Res (2014) 0.79
Ultrastructural and molecular analyzes of insulin-producing cells induced from human hepatoma cells. Cytotherapy (2010) 0.79
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance. Cancer Chemother Pharmacol (2012) 0.79
Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells. Cancer Chemother Pharmacol (2009) 0.79
Development and morphogenesis of human wrist joint during embryonic and early fetal period. J Anat (2012) 0.79
Quantitative structure-activity relationships for a series of symmetrical bisquaternary anticancer compounds. Bioorg Med Chem (2002) 0.79
Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem (2005) 0.78
Relationship of body mass index and body fat distribution with postural balance and risk of falls in Spanish postmenopausal women. Menopause (2013) 0.78
E phage gene transfection enhances sensitivity of lung and colon cancer cells to chemotherapeutic agents. Int J Oncol (2010) 0.78
Cinnamoyl nitrogen mustard derivatives of pyrazole analogues of tallimustine modified at the amidino moiety: design, synthesis, molecular modeling and antitumor activity studies. Bioorg Med Chem (2004) 0.78
Insight into the inhibition of human choline kinase: homology modeling and molecular dynamics simulations. ChemMedChem (2006) 0.78
Characterization of the satellite DNA Msat-160 from species of Terricola (Microtus) and Arvicola (Rodentia, Arvicolinae). Genetica (2010) 0.78
The cytotoxic activity of the phage E protein suppress the growth of murine B16 melanomas in vitro and in vivo. J Mol Med (Berl) (2009) 0.78
Transdifferentiation: why and how? Cell Biol Int (2011) 0.78